Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.265 USD | -3.69% | -2.25% | -44.85% |
04/04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
08/01 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.74Cr 479.03Cr |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 16Cr 1.31TCr | Net cash position 2025 * | 20Cr 1.64TCr | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 119 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.62% |
1 day | -3.69% | ||
1 week | -2.25% | ||
Current month | -2.83% | ||
1 month | -12.93% | ||
3 months | -36.97% | ||
6 months | -14.75% | ||
Current year | -44.85% |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 3.265 | -3.69% | 56 752 |
12/24/12 | 3.39 | +0.30% | 124,413 |
11/24/11 | 3.38 | +0.60% | 245,547 |
10/24/10 | 3.36 | +0.30% | 177,625 |
07/24/07 | 3.35 | +0.30% | 143,166 |
Delayed Quote Nasdaq, June 14, 2024 at 12:10 am IST
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.85% | 5.74Cr | |
+17.56% | 12TCr | |
+16.43% | 11TCr | |
-9.38% | 2.36TCr | |
+4.40% | 2.26TCr | |
-38.15% | 1.76TCr | |
-7.24% | 1.76TCr | |
-15.36% | 1.73TCr | |
+3.62% | 1.35TCr | |
+28.56% | 1.13TCr |
- Stock Market
- Equities
- MURA Stock